Home | Search | Results place holder

Search Results



place holder place holder place holder place holder place holder place holder place holder place holder

Results for 'Pipeline and Commercial Insight: Alzheimer's Disease'

Title Sort Publication Date Sort Price Sort Relevance Sort
place holder


Pipeline and Commercial Insight: Alzheimer's Disease
Scenario Forecasts Reveal Vast Market Potential

 March 2008 £7600 100 %
Pipeline And Commercial Insight: Parkinson's Disease
Market To Grow As First Round Of Lifecycle Management Strategies Succeed

 September 2007 £7600 71 %
Commercial and Pipeline Insight: Inflammatory Bowel Disease
Competition Increases for the Biologics

 November 2006 £6000 70 %
Commercial and Pipeline Insight: Inflammatory Bowel Disease
Competition Increases for the Biologics

 November 2006 £6000 70 %
Multiple Myeloma - Exploring New Targets For Multiple Drug Therapy
Stakeholder Opinions

 December 2007 £2000 35 %
Stakeholder Insight: Alzheimer's Disease
Prescribing trends indicate that neurologists are not adhering to guidelines

 December 2006 £8000 33.6 %
Stakeholder Opinions: Cystic Fibrosis

 March 2006 £2195 31.5 %
Stakeholder Opinions: Head and Neck Cancer
Innovatives to Change the Face of Treatment

 November 2007 £2000 30 %
Stakeholder Opinions: Respiratory Syncytial Virus (RSV)
A market yet to reach its full potential

 December 2006 £2000 29 %
Stakeholder Opinions Respiratory Syncytial Virus (RSV)
A market yet to reach its full potential

 January 2007 £2000 29 %
Pipeline Insight: Parkinson's Disease and Restless Legs Syndrome
Reformulations set to drive near-term growth

 August 2006 £8695 28.5 %
Pipeline Insight: Orphan Diseases in CNS - Part I: Huntington's Disease

 November 2007 £3800 28 %
Stakeholder Opinions: Melanoma
Lucrative commercial opportunities persist

 December 2006 £2000 27 %
Commercial Insight Antithrombotics
Pipeline products to dampen the impact of patent expiries and cost containment initiatives

 February 2007 £8000 26.6 %
Stakeholder Opinions: Biologics in Infectious Diseases
Well Defined Target Populations Are Key to Commercial Success

 March 2008 £2000 26.25 %
Pipeline Insight: Therapeutic Cancer Vaccines
A turbulent path from bench to bedside

 December 2006 £6000 23.8 %
Stakeholder Opinions: Osteoarthritis
Preconceptions Damage Awareness and Treatments

 March 2006 £2195 23 %
Pipeline/Commercial Insight: Innovative Targeted Therapies
Smart Drugs' on Target for Increasing Growth

 October 2005 £8695 21.7 %
Stakeholder Opinions: Bone Metastases
Impending Patent Expiries May Help Make or Break Newer Agents

 March 2008 £2000 21 %
Colorectal Cancer: Pipeline/Commercial Insight
Shaping the future dynamics of colorectal cancer management

 October 2006 £8000 21 %
Stakeholder Perspectives: Pulmonary Arterial Hypertension
A small market gets big attention

 February 2006 £4350 21 %
Pipeline Insight: Chronic and Acute Heart Failure
Diversity and Disappointment

 December 2005 £6495 21 %
Pipeline Insight: Cancer Vaccines and Cell Therapies
Technical Know How Needs Translation Into Clinical and Commercial Rewards

 April 2005 £6000 19.95 %
Pancreatic Cancer
Gold Standard Gemcitabine Waiting to be Challenged

 December 2004 £8000 19.25 %
Pipeline Insight: Breast Cancer
Recent approvals increase pressure on pipeline candidates

 April 2008 £6000 19.25 %
Stakeholder Opinions: Systemic Lupus Erythematosus
Market Set to Enter Era of Biologic Therapies

 March 2008 £2000 19.25 %
Commercial and Pipeline Insight
Vaccines for Adults and The Elderly - New Blockbuster Opportunities Ahead

 July 2008 £7700 18.55 %
Commercial and Pipeline Insight
Vaccines for Adults and The Elderly - New Blockbuster Opportunities Ahead

 July 2008 £7700 18.55 %
Pipeline Insight: Nosocomial Vaccines
Minefield or Goldmine?

 April 2008 £6000 18.2 %
Innovations in Cancer
Novel Therapeutics, New Diagnostics and Future R&D Strategies

 February 2007 £1495 18 %
Maximizing Product Returns Through Reformulation
Old Molecules, New Opportunities

 August 2004 £8000 17.5 %
Commercial and Pipeline Insight: ADHD
Immature adult market continues to offer greatest commercial potential

 April 2008 £8000 17.5 %
Commercial Insight: HIV
Simplicity and Survival

 August 2005 £8000 17.5 %
Pipeline Insight: Acute Stroke
Commercial Risk Offsets High Unmet Need

 May 2008 £6000 17.5 %
Commercial and Pipeline Insight: Psoriasis
Anti-TNF's lead another indication

 December 2006 £8000 17.15 %
Commercial Insight: Multiple Sclerosis Continued growth makes the MS market a highly attractive investment

 June 2007 £7600 16.1 %
Pipeline Insight: Non-Small Cell Lung Cancer
Pipeline set to offer only modest improvements

 April 2008 £6000 16.1 %
Stakeholder Opinions: Gynecological Cancers
Niche opportunities in advanced disease

 December 2006 £2000 16.1 %
Lymphoma
A Therapeutic & Competitive Insight

 May 2006 £1325 16 %
Triple Progress Analysis: Melanoma, Colorectal & Lung Cancer

 March 2006 £2340 16 %
Stakeholder Opinions: Fibromyalgia - Potentially lucrative market soon to become reality

 May 2007 £2000 15.75 %
Pipeline Insight: Antithrombotics
Anticoagulants and Antiplatelets Have Blockbuster Potential

 October 2005 £6495 15.4 %
Triple Analysis: Non Small Cell Lung Cancer, Protein Kinase Inhibitors & Anti-Angiogenic Agents

 October 2006 £2340 15 %
Stakeholder Insight: Prostate Cancer Treatment in the USA

 September 2004 £8000 14.7 %
Current and Future Therapies for Lung Cancer
A Therapeutic & Competitive Insight

 March 2006 £1325 14.5 %
Pipeline Insight: Epilepsy
Pipeline drugs struggle to outshine their marketed predecessors

 October 2006 £6000 14.35 %
Pipeline Insight: Osteoarthritis
The Wait for a DMOAD Continues

 November 2006 £6000 14.35 %
Commercial and Pipeline Insight: Hepatitis B

 October 2007 £7600 14 %
Targeted Therapeutics in Non-Small Cell Lung Cancer

 April 2007 £1325 14 %
Pipeline/Commercial Insight: Antihypertensives New class opportunity offset by key patent expiries

 July 2007 £7600 13.65 %
Antiageing and Life Enhancement Pharmacotherapeutics

 January 2006 £4600 13 %
Pipeline Insight: Hepatitis C
Protease inhibitors to drive market expansion

 June 2006 £6495 12.6 %
Hematological Cancers - A Therapeutic & Competitive Insight

 October 2006 £2000 12 %
Pipeline/Commercial Insight: Supportive Care in Oncology
Significant growth opportunities exist in new supportive care indications

 June 2007 £7600 11.55 %
Commercial Insight: Neuropathic Pain
A Plethora of Patient Segmentation and Product Differentiation Opportunities

 July 2006 £8440 10.85 %
Commercial Insight: Antidiabetics
Patent expiries and cost containment initiatives balanced by pipeline products

 August 2006 £8695 10.85 %
Antihormonal Therapies
Aromatase Inhibitors Reinvigorate a Mature Market

 July 2005 £8000 10.5 %
Commercial and Pipeline Insight: Systemic antifungals

 November 2007 £7600 10.15 %
Pipeline/Commercial Insight: Molecular Targeted Cancer Therapies
More drugs on the market, more targets in the pipeline

 October 2006 £8000 10.15 %
Commercial Insight: Antihypertensives
New challenges for a maturing market

 September 2006 £8000 9.1 %
Commercial Insight: Asthma & COPD - Combination products still have blockbuster potential
Combination Products Still Have Blockbuster Potential

 July 2007 £7600 8.05 %
place holder